Swendeman, Dallas https://orcid.org/0000-0002-4570-6352
Rotheram-Borus, Mary Jane
Arnold, Elizabeth Mayfield
Fernández, Maria Isabel
Comulada, W. Scott
Ishimoto, Kelsey
Gertsch, William
Murphy, Debra A.
Ocasio, Manuel
Lee, Sung-Jae
Lewis, Katherine A.
,
Abdalian, Sue Ellen
Bolan, Robert
Bryson, Yvonne
Chaplin, Antwon
Cortado, Ruth
Donahue, Catherine
Duan, Naihua
Flynn, Risa
Fournier, Jasmine
Jimenez, Sergio
Kerin, Tara
Klausner, Jeffrey
Kussin, Jody
Lightfoot, Marguerita
Milburn, Norweeta
Mosafer, Jasmine
Moses, Aaron
Nielsen, Karin
Ramos, Wilson
Reback, Cathy J.
Rezvan, Panteha Hayati
Tang, Wenze
Tapia, Yara
Thomas, Demi
Urauchi, Stacey
Weiss, Robert E.
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (U19HD089886)
National Institute of Mental Health (U19HD089886, P30MH058107)
National Institute on Drug Abuse (U19HD089886)
National Institute on Minority Health and Health Disparities (U19HD089886)
Center for HIV Identification, Prevention, and Treatment Services, University of California, Los Angeles (P30MH058107)
Center for AIDS Research, University of California Los Angeles (P30AI028697)
Clinical and Translational Science Institute, University of California, Los Angeles (UL1TR001881)
Article History
Accepted: 3 November 2024
First Online: 28 November 2024
Declarations
:
: Dr. Arnold was a consultant on project funded by Merck, Sharpe, and Dohme and has current funding from this entity. However, these projects are not related to the current study/manuscript. The other authors declare no competing interests, financial or non-financial.
: All study methods were approved by the IRB. The Institutional Review Board (IRB) of the University of California, Los Angeles served as the single IRB of Record for each collaborating university/agency partner (#16-001674-CR-00003), and the trial was registered at clinicaltrials.gov (#03134833).
: All participants provided informed consent per the IRB-approved process.